Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome
Author(s) -
Somayeh Arabzadeh,
Ghamartaj Hossein,
Batool Hossein Rashidi,
Marziyeh Agha Hosseini,
Hojjat Zeraati
Publication year - 2010
Publication title -
annals of saudi medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.373
H-Index - 44
eISSN - 0975-4466
pISSN - 0256-4947
DOI - 10.4103/0256-4947.71063
Subject(s) - polycystic ovary , in vitro fertilisation , follicular fluid , anti müllerian hormone , basal (medicine) , medicine , endocrinology , follicular phase , human fertilization , ovary , hormone , ovarian reserve , andrology , biology , infertility , oocyte , insulin resistance , embryo , microbiology and biotechnology , pregnancy , anatomy , obesity , insulin , genetics
The prediction of in vitro fertilization (IVF) outcomes by anti-Müllerian hormone (AMH) measurement is getting increasing attention from clinicians. This study compares the relationship between serum or intrafollicular AMH levels and IVF outcomes in women with and without polycystic ovary syndrome (PCOS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom